GSK (GSK LN) has received expanded US age indication approval in the US for Arexvy
Importance
Level 1
#UNITED KINGDOM#EUROPE#GLAXOSMITHKLINE PLC#GSK.LN#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100 INDEX#GSK PLC#GSK#FTSE 100